CN1292737C - Oral administration dripping pill for nourishing heart to calm mind and its preparing method - Google Patents

Oral administration dripping pill for nourishing heart to calm mind and its preparing method Download PDF

Info

Publication number
CN1292737C
CN1292737C CNB2005100074203A CN200510007420A CN1292737C CN 1292737 C CN1292737 C CN 1292737C CN B2005100074203 A CNB2005100074203 A CN B2005100074203A CN 200510007420 A CN200510007420 A CN 200510007420A CN 1292737 C CN1292737 C CN 1292737C
Authority
CN
China
Prior art keywords
polyethylene glycol
drop pill
substrate
mixed
drug extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2005100074203A
Other languages
Chinese (zh)
Other versions
CN1682804A (en
Inventor
曲韵智
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Chia Tai Green Continent Pharmaceutical Co Ltd
Original Assignee
Beijing Chia Tai Green Continent Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Chia Tai Green Continent Pharmaceutical Co Ltd filed Critical Beijing Chia Tai Green Continent Pharmaceutical Co Ltd
Priority to CNB2005100074203A priority Critical patent/CN1292737C/en
Publication of CN1682804A publication Critical patent/CN1682804A/en
Application granted granted Critical
Publication of CN1292737C publication Critical patent/CN1292737C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a medical composition oral preparation having the effects of consolidating exterior by invigorating qi, tranquilizing by nourishing the heart and harmonizing the stomach by fortifying the spleen, and the medical composition oral preparation is used for treating diseases, such as the dual vacuity of the heart and spleen, the little thought of food and drink, abdominal distention and fullness, qi shortage weakness, flusteredness palpitation, spirit fatigue, insomnia, etc. The present invention aims to supply the insufficiency of the existing medical oral preparation for treating diseases, such as the dual vacuity of the heart and spleen, the little thought of food and drink, abdominal distention and fullness, qi shortage weakness, flusteredness palpitation, spirit fatigue, insomnia, etc., and provide a dripping pill Kangfuchun having the advantages of high biologic utilization, rapid medicine release, high effect taking speed, high medicine content, precise taking amount, low price and convenient carrying. The dripping pill Kangfuchun of the present invention uses traditional Chinese medicine such as astragalus root, ginseng, polygonatum and royal jelly as raw materials, and the dripping pill Kangfuchun and a medical carrier as a base material can be prepared together.

Description

A kind of oral administration dripping pill and preparation method thereof with tranquilizing by nourishing the heart effect
Technical field
The present invention relates to a kind of benefiting QI for strengthening the superficies that has, tranquilizing by nourishing the heart, the invigorating the spleen and regulating the stomach effect, it is all empty to be used for the treatment of heart spleen, and diet is thought less, the abdominal distention abdominal distention, weak breath is weak, nervous cardiopalmus, tired mind, the pharmaceutical composition of diseases such as insomnia is a kind of drug composition oral preparation that feedstock production forms with 4 flavor Chinese medicines such as the Radix Astragali, Radix Ginseng, Rhizoma Polygonati Odorati, Lac regis apis particularly.
Background technology
According to drug standard WS promulgated by the ministries or commissions of the Central Government 3The rehabilitation spring oral liquid that the preparation method that provides among-the B-3987-98 is prepared from, it is a kind of benefiting QI for strengthening the superficies that has, tranquilizing by nourishing the heart, the invigorating the spleen and regulating the stomach effect, it is all empty to be used for heart spleen, diet is thought less, the abdominal distention abdominal distention, weak breath is weak, nervous cardiopalmus, tired mind, the syrups oral formulations of disease treatments such as insomnia.This product to coronary heart disease cause uncomfortable in chest pained, the hyperhidrosis of breathing hard, the left ventricle contractile function goes down, and to hyperlipemia, the Glutamate pyruvate transaminase rises that acute and chronic active hepatitis causes all has the auxiliary treatment effect, through clinical verification, determined curative effect is the common drug that clinical and family is used for the treatment of above-mentioned disease.Below be drug standard WS 3Prescription that provides among-the B-3987-98 and technology and brief description:
Prescription: Radix Astragali 200g, Radix Ginseng 7.5g, Rhizoma Polygonati Odorati 10g, Lac regis apis 25g
Method for making: above four flavors, the Radix Astragali, Radix Ginseng, Rhizoma Polygonati Odorati are given as one thinks fit cataclasm, add water logging after 2 hours, decoct three times, each 1~1.5 hour, collecting decoction filtered, filtrate decompression is concentrated into 2 times of amounts of medical material, adds ethanol and makes and contain the alcohol amount and reach 70%, fully stirs, cold preservation 24 hours filters, and filtrate recycling ethanol is to there not being the alcohol flavor, add Lac regis apis diluent and correctives, antiseptic is an amount of, regulates pH value to 3.5~5.0, add water and adjust total amount to 1000ml, filter, embedding, promptly.
Function cures mainly: benefiting QI for strengthening the superficies, tranquilizing by nourishing the heart, invigorating the spleen and regulating the stomach.It is all empty to be used for heart spleen, and diet is thought less, the abdominal distention abdominal distention, and weak breath is weak, nervous cardiopalmus, tired mind, insomnia.This product to coronary heart disease cause uncomfortable in chest pained, the hyperhidrosis of breathing hard, the left ventricle contractile function goes down, and to hyperlipemia, the Glutamate pyruvate transaminase rises that acute and chronic active hepatitis causes all has the auxiliary treatment effect.
Owing to reasons such as technologies of preparing, the oral formulations of most drug, especially the oral formulations of Chinese medicine, exist all after taking that dissolve scattered time limit is long, dissolution is low, absorption is relatively poor, problem such as liver sausage first pass effect and bioavailability are lower, thereby influence the performance of drug effect, also directly affect therapeutic effect.And the syrups oral formulations also exist medicament contg low, take metering and be difficult to accurately, take or carry shortcomings such as inconvenience.
In addition, conventional peroral dosage form as tablet, capsule etc., because the technology of granulation is arranged, therefore can produce bigger dust pollution in preparation process, can staff's health be worked the mischief to a certain extent, also can cause certain pollution to environment simultaneously.Moreover, the complex manufacturing of conventional oral formulations, production cost is higher, thereby patient's drug cost is also improved thereupon, is unfavorable for improving the ability of seeking medical advice of extensive patients, also is unfavorable for improving the general health level of society.
Summary of the invention
Purpose of the present invention is to replenish the existing all void of heart spleen that is used for the treatment of, and diet is thought less, the abdominal distention abdominal distention, weak breath is weak, nervous cardiopalmus, tired mind, the deficiency of the oral drug preparation of diseases such as insomnia provides a kind of bioavailability height, and has a quick release, quick produce effects, the medicament contg height is taken accurate measurement, cheap, and portable rehabilitation spring drop pill.
Rehabilitation spring drop pill involved in the present invention is a raw material with 4 flavor Chinese medicines such as the Radix Astragali, Radix Ginseng, Rhizoma Polygonati Odorati, Lac regis apis, after extraction obtains containing the extract of pharmaceutically active ingredient in above 4 flavors, is prepared from the pharmaceutically suitable carrier as substrate again.Be prepared by the following technical solutions, can obtain rehabilitation spring drop pill involved in the present invention:
[preparation method]
1. active pharmaceutical ingredient: the extract that contains pharmaceutically active ingredient in 4 flavors such as the Radix Astragali, Radix Ginseng, Rhizoma Polygonati Odorati, Lac regis apis;
2. substrate: Polyethylene Glycol (2000~20000), one or more the mixture in pharmaceutically suitable carrier such as polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, sodium lauryl sulphate, stearic acid, sodium stearate, glycerin gelatine, Lac;
3. proportioning: with g or kg is unit, by weight, and drug extract: substrate=1: 1~1: 9;
4. according to the given ratio of prescription, accurately take by weighing drug extract and substrate, be placed on heating while stirring in the heating container, standby until the fused solution that obtains containing drug extract and substrate and/or emulsion and/or suspension;
5. adopt homemade or general drop pill machine (as the TZDW-1 type drop pill machine of Changzheng Tianmin High Science ﹠ Technology Co., Ltd., Beijing's production), and the temperature control system of adjustment drop pill machine, make the water dropper temperature heating of drop pill machine and remain on (50~90) ℃, the temperature cooling of condensing agent also remains on (40~-5) ℃;
6. when treating that the temperature of condensing agent in dropping-pill machine head and the condensation column is stable respectively and reaching desired state of temperature, fused solution and/or the emulsion and/or the suspension that will contain drug extract and substrate, place in the water dropper jar of drop pill machine, splash in the condensing agent, condensing agent can be any one in liquid paraffin, methyl-silicone oil, the vegetable oil;
7. will shrink the drop pill taking-up of molding by the outlet of drop pill machine, remove the surface condensation agent, be drying to obtain.
[appendix: a kind of preparation method of drug extract] is unit with g, get Radix Astragali 200g, Radix Ginseng 7.5g, Rhizoma Polygonati Odorati 10g, Lac regis apis 25g, more than four the flavor, with the Radix Astragali, Radix Ginseng, Rhizoma Polygonati Odorati is given as one thinks fit cataclasm, adds water logging after 2 hours, decoct three times, each 1~1.5 hour, collecting decoction filtered, filtrate decompression is concentrated into 2 times of amounts of medical material, add ethanol and make and contain the alcohol amount and reach 70%, fully stir cold preservation 24 hours, filter, filtrate recycling ethanol adds Lac regis apis to there not being the alcohol flavor, decompression (0.1MPa), be condensed into relative density under low temperature (60 ℃) condition and be 1.3~1.35 thick paste, perhaps continue to make drying, be ground into dry powder, promptly.
Beneficial effect
According to drug standard WS promulgated by the ministries or commissions of the Central Government 3The rehabilitation spring oral liquid that the preparation method that provides among-the B-3987-98 is prepared from, it is a kind of benefiting QI for strengthening the superficies that has, tranquilizing by nourishing the heart, the invigorating the spleen and regulating the stomach effect, it is all empty to be used for heart spleen, diet is thought less, the abdominal distention abdominal distention, weak breath is weak, nervous cardiopalmus, tired mind, the syrups oral formulations of disease treatments such as insomnia.This product to coronary heart disease cause uncomfortable in chest pained, the hyperhidrosis of breathing hard, the left ventricle contractile function goes down, and to hyperlipemia, the Glutamate pyruvate transaminase rises that acute and chronic active hepatitis causes all has the auxiliary treatment effect, through clinical verification, determined curative effect is the common drug that clinical and family is used for the treatment of above-mentioned disease.
Owing to reasons such as technologies of preparing, the oral formulations of most drug, especially the oral formulations of Chinese medicine, exist all after taking that dissolve scattered time limit is long, dissolution is low, absorption is relatively poor, problem such as liver sausage first pass effect and bioavailability are lower, thereby influence the performance of drug effect, also directly affect therapeutic effect.And the syrups oral formulations also exist medicament contg low, take metering and be difficult to accurately, take or carry shortcomings such as inconvenience.
In addition, conventional peroral dosage form as tablet, capsule etc., because the technology of granulation is arranged, therefore can produce bigger dust pollution in preparation process, can staff's health be worked the mischief to a certain extent, also can cause certain pollution to environment simultaneously.Moreover, the complex manufacturing of conventional oral formulations, production cost is higher, thereby patient's drug cost is also improved thereupon, is unfavorable for improving the ability of seeking medical advice of extensive patients, also is unfavorable for improving the general health level of society.
Rehabilitation spring drop pill involved in the present invention is compared with rehabilitation spring oral liquid has following beneficial effect:
1. rehabilitation spring drop pill involved in the present invention; utilize surfactant to be substrate; the extract of pharmaceutically active ingredient is made solid dispersion in containing 4 flavors such as the Radix Astragali, Radix Ginseng, Rhizoma Polygonati Odorati, Lac regis apis; making medicine be molecule, colloid or microcrystalline state is scattered in the substrate; the total surface area of medicine increases; and substrate is hydrophilic; medicine had wetting action; can make medicine molten microgranule or the solution of loosing into rapidly; thereby make the dissolving of medicine and absorb quickening; thereby improved bioavailability, brought into play efficient, quick-acting effects etc.
2. rehabilitation spring drop pill involved in the present invention, contact promptly with saliva and to dissolve rapidly, and absorb by oral mucosa, not only rapid-action, and the influence of not taken food, promptly all can containing take after meal ante cibum, can not produce any residual harmful substance at gastric yet, thereby make that patient's medication is safer, also have medication convenience, characteristic of accurate simultaneously.
3. rehabilitation spring drop pill involved in the present invention mixes the extract that contains active constituents of medicine mutually with molten matrix, splashes in the not miscible condensed fluid and makes.Therefore, the stability of drug height, not facile hydrolysis, oxidation, and the operation be under liquid state, to carry out, no dust pollution is not subject to the influence of crystal formation, thereby has guaranteed the quality of medicine, has increased stability.
4. production technology, the equipment of preparation drop pill are simple, easy to operate, the automaticity height, and labor intensity is low, the production efficiency height.Workshop does not have dust simultaneously, helps labor protection and environmental protection yet.
5. the production cost of preparation drop pill is usually with about 50% of other oral formulations of kind, and compares with oral liquid, and the dosage of drop pill is accurate, thereby makes the patient take metering control easily.
The specific embodiment
Now with several groups of specific embodiments, the preparation method of drop pill is described further with regard to the rehabilitation of the present invention spring.
First group: the test of single-matrix
1. the preparation of drug extract: be prepared according to [appendix: a kind of preparation method of drug extract], the extract dry powder that obtains containing pharmaceutically active ingredient in 4 flavors such as the Radix Astragali, Radix Ginseng, Rhizoma Polygonati Odorati, Lac regis apis is standby;
2. substrate: Polyethylene Glycol (2000,4000,6000,8000,10000,20000), polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, sodium lauryl sulphate, stearic acid, sodium stearate, glycerin gelatine, Lac etc.;
3. proportioning: with g or kg is unit, by weight, and drug extract: substrate=1: 1~1: 9;
4. the process that provides according to [preparation method] 4~7 is prepared, and can obtain the rehabilitation spring drop pill of different size.
[result of the test]
Test 1: for observe drug extract and different substrates when 1: 1 the proportioning prepared rehabilitation spring drop pill in qualitative difference, according to 1: 1 ratio, with drug extract respectively with Polyethylene Glycol 2000, Polyethylene Glycol 4000, Polyethylene Glycol 6000, Polyethylene Glycol 8000, Polyethylene Glycol 10000, Polyethylene Glycol 20000, pharmaceutically suitable carrier such as polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, sodium lauryl sulphate, stearic acid, sodium stearate, glycerin gelatine, Lac matches, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain 15 pharmaceutical compositions experiments that contain drug extract and different substrates, and obtain 15 groups of different experimental results and see Table 1.
Test 2: for observe drug extract and different substrates when 1: 3 the proportioning prepared rehabilitation spring drop pill in qualitative difference, according to 1: 3 ratio, with drug extract respectively with Polyethylene Glycol 2000, Polyethylene Glycol 4000, Polyethylene Glycol 6000, Polyethylene Glycol 8000, Polyethylene Glycol 10000, Polyethylene Glycol 20000, pharmaceutically suitable carrier such as polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, sodium lauryl sulphate, stearic acid, sodium stearate, glycerin gelatine, Lac matches, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain 15 pharmaceutical compositions experiments that contain drug extract and different substrates, and obtain 15 groups of different experimental results and see Table 2.
Test 3: for observe drug extract and different substrates when 1: 9 the proportioning prepared rehabilitation spring drop pill in qualitative difference, according to 1: 9 ratio, with drug extract respectively with Polyethylene Glycol 2000, Polyethylene Glycol 4000, Polyethylene Glycol 6000, Polyethylene Glycol 8000, Polyethylene Glycol 10000, Polyethylene Glycol 20000, pharmaceutically suitable carrier such as polyoxyethylene stearate 40 esters, betacyclodextrin, poloxamer, carboxymethyl starch sodium, sodium lauryl sulphate, stearic acid, sodium stearate, glycerin gelatine, Lac matches, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain 15 pharmaceutical compositions experiments that contain drug extract and different substrates, and obtain 15 groups of different experimental results and see Table 3.
Second group: the test of mixed-matrix
1. the preparation of drug extract: be prepared according to [appendix: a kind of preparation method of drug extract], the extract dry powder that obtains containing pharmaceutically active ingredient in 4 flavors such as the Radix Astragali, Radix Ginseng, Rhizoma Polygonati Odorati, Lac regis apis is standby;
2. substrate:
2.1 Polyethylene Glycol---English name Macrogol,
2.2 polyoxyethylene stearate 40 esters---English name Polyoxyl (40) Stearate,
Molecular formula is with C 17H 35COO (CH 2CH 2O) nH represents that n is about 40,
2.3 poloxamer---English name Poloxamer, polyoxyethylene poly-oxygen propylene aether,
Molecular formula HO (C 2H 4O) a(C 3H 6O) b(C 2H 4O) cH,
The sodium salt of the starch carboxymethyl ester that 2.4 carboxymethyl starch sodium---English name Carboxymethylstach Sodium, starch generates with the monoxone effect under alkali condition,
2.5 betacyclodextrin---English name Betacyclodextrin, molecular formula C 6H 10O 5, this product is that ring dextrin glucosyl transferase acts on 7 glucoses that starch generates with α-1, the bonded cyclic oligosaccharide of 4-glycosidic bond;
3. proportioning: with g or kg is unit, by weight, and drug extract: substrate=1: 1~1: 9;
4. the process that provides according to [preparation method] 4~7 is prepared, and can obtain the rehabilitation spring drop pill of different size.
[result of the test]
Test 4: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared rehabilitation spring drop pill when 1: 1 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 1 mixed evenly as mixed-matrix, according to 1: 1 ratio different with the 4 kinds respectively mixing matrix phases of drug extract are mixed again and make evenly, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experimental results and see Table 4.
Test 5: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared rehabilitation spring drop pill when 1: 3 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 1 mixed evenly as mixed-matrix, according to 1: 3 ratio different with the 4 kinds respectively mixing matrix phases of drug extract are mixed again and make evenly, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experimental results and see Table 5.
Test 6: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared rehabilitation spring drop pill when 1: 9 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 1 mixed evenly as mixed-matrix, according to 1: 9 ratio different with the 4 kinds respectively mixing matrix phases of drug extract are mixed again and make evenly, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experimental results and see Table 6.
Test 7: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared rehabilitation spring drop pill when 1: 1 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 5 mixed evenly as mixed-matrix, according to 1: 1 ratio different with the 4 kinds respectively mixing matrix phases of drug extract are mixed again and make evenly, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experimental results and see Table 7.
Test 8: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared rehabilitation spring drop pill when 1: 3 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 5 mixed evenly as mixed-matrix, according to 1: 3 ratio different with the 4 kinds respectively mixing matrix phases of drug extract are mixed again and make evenly, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experimental results and see Table 8.
Test 9: in order to observe the mass discrepancy of drug extract and mixed-matrix prepared rehabilitation spring drop pill when 1: 9 the proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 5 mixed evenly as mixed-matrix, according to 1: 9 ratio different with the 4 kinds respectively mixing matrix phases of drug extract are mixed again and make evenly, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experimental results and see Table 9.
Test 10: in order to observe the mass discrepancy of drug extract and mixed-matrix obtained rehabilitation spring drop pill when 1: 1 proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 10 mixed evenly as mixed-matrix, according to 1: 1 ratio drug extract is mixed mutually with 4 kinds of different mixed-matrixes respectively again and make evenly, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experimental results and see Table 10.
Test 11: in order to observe the mass discrepancy of drug extract and mixed-matrix obtained rehabilitation spring drop pill when 1: 3 proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 10 mixed evenly as mixed-matrix, according to 1: 3 ratio drug extract is mixed mutually with 4 kinds of different mixed-matrixes respectively again and make evenly, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experimental results and see Table 11.
Test 12: in order to observe the mass discrepancy of drug extract and mixed-matrix obtained rehabilitation spring drop pill when 1: 9 proportioning, with polyoxyethylene stearate 40 esters, poloxamer, carboxymethyl starch sodium, 4 kinds of carriers such as betacyclodextrin respectively with Polyethylene Glycol with 1: 10 mixed evenly as mixed-matrix, according to 1: 9 ratio drug extract is mixed mutually with 4 kinds of different mixed-matrixes respectively again and make evenly, adopt homemade drop pill machine, be prepared according to the step of stipulating in the preparation method, can obtain the experiment of 4 pharmaceutical compositions that drug extract and mixed-matrix constituted, and obtain 4 groups of different experimental results and see Table 12.
The group practices of table 1 drug extract and single-matrix
(drug extract: substrate=1: 1)
The substrate title Effective ingredient (%) Rounding rate (%) Dissolve scattered time limit (minute) The ball method of double differences different (%) Hardness
Polyethylene Glycol 2000 50.0 64 <30 >10 +
Polyethylene Glycol 4000 50.0 76 <30 >10 +
Polyethylene Glycol 6000 50.0 80 <30 >10 ++
Polyethylene Glycol 8000 50.0 83 <30 >10 ++
Polyethylene Glycol 10000 50.0 85 <30 >10 ++
Polyethylene Glycol 20000 50.0 86 <30 >10 ++
Polyoxyethylene stearate 40 esters 50.0 74 <30 >10 ++
Betacyclodextrin 50.0 72 <30 >10 +
Poloxamer 50.0 73 <30 >10 ++
Carboxymethyl starch sodium 50.0 71 <30 >10 +
Sodium lauryl sulphate 50.0 69 >30 >10 ++
Stearic acid 50.0 58 >30 >10 ++
Sodium stearate 50.0 54 >30 >10 ++
Glycerin gelatine 50.0 56 >30 >10 +
Lac 50.0 53 >30 >10 +
The group practices of table 2 drug extract and single-matrix
(drug extract: substrate=1: 3)
The substrate title Effective ingredient (%) Rounding rate (%) Dissolve scattered time limit (minute) The ball method of double differences different (%) Hardness
Polyethylene Glycol 2000 25.0 79 <30 >10 ++
Polyethylene Glycol 4000 25.0 86 <30 <10 +++
Polyethylene Glycol 6000 25.0 91 <30 <10 +++
Polyethylene Glycol 8000 25.0 91 <30 <10 +++
Polyethylene Glycol 10000 25.0 92 <30 <10 +++
Polyethylene Glycol 20000 25.0 92 <30 <10 +++
Polyoxyethylene stearate 40 esters 25.0 93 <30 <10 ++
Betacyclodextrin 25.0 83 <30 >10 ++
Poloxamer 25.0 91 <30 <10 +++
Carboxymethyl starch sodium 25.0 86 <30 <10 +++
Sodium lauryl sulphate 25.0 77 <30 >10 ++
Stearic acid 25.0 73 >30 >10 +++
Sodium stearate 25.0 71 >30 >10 +++
Glycerin gelatine 25.0 70 >30 >10 +++
Lac 25.0 70 >30 >10 +++
The group practices of table 3 drug extract and single-matrix
(drug extract: substrate=1: 9)
The substrate title Effective ingredient (%) Rounding rate (%) Dissolve scattered time limit (minute) The ball method of double differences different (%) Hardness
Polyethylene Glycol 2000 10.0 84 <30 >10 ++
Polyethylene Glycol 4000 10.0 88 <30 <10 +++
Polyethylene Glycol 6000 10.0 93 <30 <10 +++
Polyethylene Glycol 8000 10.0 93 <30 <10 +++
Polyethylene Glycol 10000 10.0 92 <30 <10 +++
Polyethylene Glycol 20000 10.0 94 <30 <10 +++
Polyoxyethylene stearate 40 esters 10.0 89 <30 <10 ++
Betacyclodextrin 10.0 87 <30 <10 ++
Poloxamer 10.0 92 <30 <10 +++
Carboxymethyl starch sodium 10.0 82 <30 >10 +++
Sodium lauryl sulphate 10.0 81 <30 >10 +++
Stearic acid 10.0 79 >30 >10 +++
Sodium stearate 10.0 80 >30 >10 +++
Glycerin gelatine 10.0 76 >30 >10 +++
Lac 10.0 78 >30 >10 +++
The group practices of table 4 drug extract and mixed-matrix
(drug extract: mixed-matrix=1: 1)
The substrate title Effective ingredient (%) Rounding rate (%) Dissolve scattered time limit (minute) The ball method of double differences different (%) Hardness
Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 1 50 84 <30 >10 ++
Poloxamer: Polyethylene Glycol=1: 1 50 82 <30 >10 ++
Carboxymethyl starch sodium: Polyethylene Glycol=1: 1 50 79 <30 >10 ++
Betacyclodextrin: Polyethylene Glycol=1: 1 50 72 <30 >10 +
The group practices of table 5 drug extract and mixed-matrix
(drug extract: mixed-matrix=1: 3)
The substrate title Effective ingredient (%) Rounding rate (%) Dissolve scattered time limit (minute) The ball method of double differences different (%) Hardness
Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 1 25 88 <30 <10 +++
Poloxamer: Polyethylene Glycol=1: 1 25 89 <30 <10 +++
Carboxymethyl starch sodium: Polyethylene Glycol=1: 1 25 86 <30 <10 +++
Betacyclodextrin: Polyethylene Glycol=1: 1 25 82 <30 >10 ++
The group practices of table 6 drug extract and mixed-matrix
(drug extract: mixed-matrix=1: 9)
The substrate title Effective ingredient (%) Rounding rate (%) Dissolve scattered time limit (minute) The ball method of double differences different (%) Hardness
Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 1 10 88 <30 <10 +++
Poloxamer: Polyethylene Glycol=1: 1 10 86 <30 <10 +++
Carboxymethyl starch sodium: Polyethylene Glycol=1: 1 10 83 <30 >10 +++
Betacyclodextrin: Polyethylene Glycol=1: 1 10 80 <30 >10 +++
The group practices of table 7 drug extract and mixed-matrix
(drug extract: mixed-matrix=1: 1)
The substrate title Effective ingredient (%) Rounding rate (%) Dissolve scattered time limit (minute) The ball method of double differences different (%) Hardness
Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 5 50 91 <30 <10 +++
Poloxamer: Polyethylene Glycol=1: 5 50 90 <30 <10 +++
Carboxymethyl starch sodium: Polyethylene Glycol=1: 5 50 90 <30 <10 +++
Betacyclodextrin: Polyethylene Glycol=1: 5 50 86 <30 <10 ++
The group practices of table 8 drug extract and mixed-matrix
(drug extract: mixed-matrix=1: 3)
The substrate title Effective ingredient (%) Rounding rate (%) Dissolve scattered time limit (minute) The ball method of double differences different (%) Hardness
Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 5 25 93 <30 <10 +++
Poloxamer: Polyethylene Glycol=1: 5 25 93 <30 <10 +++
Carboxymethyl starch sodium: Polyethylene Glycol=1: 5 25 91 <30 <10 +++
Betacyclodextrin: Polyethylene Glycol=1: 5 25 88 <30 <10 +++
The group practices of table 9 drug extract and mixed-matrix
(drug extract: mixed-matrix=1: 9)
The substrate title Effective ingredient (%) Rounding rate (%) Dissolve scattered time limit (minute) The ball method of double differences different (%) Hardness
Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 5 10 93 <30 <10 +++
Poloxamer: Polyethylene Glycol=1: 5 10 92 <30 <10 +++
Carboxymethyl starch sodium: Polyethylene Glycol=1: 5 10 92 <30 <10 +++
Betacyclodextrin: Polyethylene Glycol=1: 5 10 89 <30 <10 +++
The group practices of table 10 drug extract and mixed-matrix
(drug extract: mixed-matrix=1: 1)
The substrate title Effective ingredient (%) Rounding rate (%) Dissolve scattered time limit (minute) The ball method of double differences different (%) Hardness
Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 10 50 92 <30 <10 +++
Poloxamer: Polyethylene Glycol=1: 10 50 91 <30 <10 +++
Carboxymethyl starch sodium: Polyethylene Glycol=1: 10 50 87 <30 <10 +++
Betacyclodextrin: Polyethylene Glycol=1: 10 50 84 <30 >10 +++
The group practices of table 11 drug extract and mixed-matrix
(drug extract: mixed-matrix=1: 3)
The substrate title Effective ingredient (%) Rounding rate (%) Dissolve scattered time limit (minute) The ball method of double differences different (%) Hardness
Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 10 25 92 <30 <10 +++
Poloxamer: Polyethylene Glycol=1: 10 25 92 <30 <10 +++
Carboxymethyl starch sodium: Polyethylene Glycol=1: 10 25 89 <30 <10 +++
Betacyclodextrin: Polyethylene Glycol=1: 10 25 87 <30 <10 +++
The group practices of table 12 drug extract and mixed-matrix
(drug extract: mixed-matrix=1: 9)
The substrate title Effective ingredient (%) Rounding rate (%) Dissolve scattered time limit (minute) The ball method of double differences different (%) Hardness
Polyoxyethylene stearate 40 esters: Polyethylene Glycol=1: 10 10 91 <30 <10 +++
Poloxamer: Polyethylene Glycol=1: 10 10 92 <30 <10 +++
Carboxymethyl starch sodium: Polyethylene Glycol=1: 10 10 91 <30 <10 +++
Betacyclodextrin: Polyethylene Glycol=1: 10 10 91 <30 <10 +++
1. can be seen by the result in the table: when the ratio of drug extract and substrate was 1: 1, its rounding rate, the ball method of double differences was different and index such as hardness is all undesirable, and dissolve scattered time limit influenced not obvious.
2. when the ratio of drug extract and substrate is 1: 3, the rounding rate, the ball method of double differences is different and index such as hardness slightly all begins to enter preferable state.
3. when the ratio of drug extract and substrate is 1: 9, the rounding rate, the ball method of double differences is different and index such as hardness improves not obvious.
4. the general effect of composite interstitial substance is better than single-matrix.
5. the hardness method for expressing in the subordinate list adopts drop pill is placed on the glass plate, press...withes one's finger it, observes its metamorphosis."+" expression flicking promptly is out of shape, " ++ " expression distortion of firmly pressing, and " +++" expression is indeformable by it.

Claims (2)

1. a rehabilitation spring drop pill that is used for the treatment of weak disease is a raw material with the Radix Astragali, Radix Ginseng, Rhizoma Polygonati Odorati, Lac regis apis, is prepared from the pharmaceutically suitable carrier as substrate, it is characterized in that:
(1) gets Radix Astragali 200g, Radix Ginseng 7.5g, Rhizoma Polygonati Odorati 10g, Lac regis apis 25g, more than four the flavor, with the Radix Astragali, Radix Ginseng, Rhizoma Polygonati Odorati is given as one thinks fit cataclasm, adds water logging after 2 hours, decocts three times, each 1~1.5 hour, collecting decoction filters, and filtrate decompression is concentrated into 2 times of amounts of medical material, adding ethanol makes and contains the alcohol amount and reach 70%, fully stir, cold preservation 24 hours filters, filtrate recycling ethanol is to there not being the alcohol flavor, add Lac regis apis, be decompressed to 0.1MPa, be condensed into relative density under 60 ℃ of cryogenic conditions and be 1.3~1.35 thick paste, or continue to make drying, be ground into dry powder, promptly get and contain the Radix Astragali, Radix Ginseng, Rhizoma Polygonati Odorati, the extract of Lac regis apis effective ingredient, standby;
(2) described substrate is the mixture of Polyethylene Glycol and polyoxyethylene stearate 40 esters or carboxymethyl starch sodium, by weight, the mixed proportion of polyoxyethylene stearate 40 esters or carboxymethyl starch sodium and Polyethylene Glycol is 1: 1~1: 10, describedly contains the extract of the Radix Astragali, Radix Ginseng, Rhizoma Polygonati Odorati, Lac regis apis effective ingredient and the ratio of substrate is 1: 3;
(3) according to aforementioned proportion, accurately take by weighing described extract and substrate, be placed in the heating container heating while stirring, standby until the fused solution that obtains containing described extract and substrate and/or emulsion and/or suspension;
(4) temperature control system of adjustment drop pill machine makes the water dropper temperature heating of drop pill machine and remains on 50 ℃~90 ℃, and the temperature cooling of condensing agent also remains on 40 ℃~-5 ℃;
When (5) temperature for the treatment of dropping-pill machine head and condensing agent is stablized described state respectively, will contain fused solution and/or the emulsion and/or the suspension of described extract and substrate, place in the water dropper jar of drop pill machine, splash in the condensing agent, shrink molding promptly.
2. rehabilitation spring drop pill as claimed in claim 1 is characterized in that: described condensing agent be methyl-silicone oil or/and liquid paraffin or/and vegetable oil.
CNB2005100074203A 2005-02-18 2005-02-18 Oral administration dripping pill for nourishing heart to calm mind and its preparing method Expired - Fee Related CN1292737C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100074203A CN1292737C (en) 2005-02-18 2005-02-18 Oral administration dripping pill for nourishing heart to calm mind and its preparing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100074203A CN1292737C (en) 2005-02-18 2005-02-18 Oral administration dripping pill for nourishing heart to calm mind and its preparing method

Publications (2)

Publication Number Publication Date
CN1682804A CN1682804A (en) 2005-10-19
CN1292737C true CN1292737C (en) 2007-01-03

Family

ID=35262423

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100074203A Expired - Fee Related CN1292737C (en) 2005-02-18 2005-02-18 Oral administration dripping pill for nourishing heart to calm mind and its preparing method

Country Status (1)

Country Link
CN (1) CN1292737C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103181562B (en) * 2011-12-31 2015-08-12 谢鸣 A kind of have health food of Summertime health-care effect and preparation method thereof
CN103396920A (en) * 2013-07-30 2013-11-20 孟宗科 Preparation method of ginseng healthcare wine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1436527A (en) * 2002-02-07 2003-08-20 王志刚 Glimepiride dripping pills
CN1546027A (en) * 2003-12-02 2004-11-17 北京正大绿洲医药科技有限公司 Dripping pills for treating allergic disease and its preparation process
CN1546141A (en) * 2003-12-12 2004-11-17 北京科信必成医药科技发展有限公司 Blumea oil dripping pills and its preparation process

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1436527A (en) * 2002-02-07 2003-08-20 王志刚 Glimepiride dripping pills
CN1546027A (en) * 2003-12-02 2004-11-17 北京正大绿洲医药科技有限公司 Dripping pills for treating allergic disease and its preparation process
CN1546141A (en) * 2003-12-12 2004-11-17 北京科信必成医药科技发展有限公司 Blumea oil dripping pills and its preparation process

Also Published As

Publication number Publication date
CN1682804A (en) 2005-10-19

Similar Documents

Publication Publication Date Title
CN1686478A (en) Cough suppressing phlegm transforming drip pill and its preparation method
CN1292737C (en) Oral administration dripping pill for nourishing heart to calm mind and its preparing method
CN1682923A (en) Body strengthening dripping pill for invigorating qi and refreshing and its preparing method
CN1307980C (en) Lemai dripping pill for treating cardiovascular diseases and its preparing method
CN1682918A (en) Tranquilizing wild jujube seed dripping pill and its preparing method
CN100341487C (en) 'Shuanghuang' antiphlogistic drop pill in use relieving inflammation and preparation method
CN1316961C (en) Grosvenor's momordica fruit drip pill an dits preparation method
CN1686342A (en) Herminium drip pill and its preparation method
CN100341489C (en) Xianling gubao dripping pills having functions of reinforcing kidney strengthening bone, and its prepn method
CN1686480A (en) Cough asthma stoppig drip pill and its preparation method
CN100344314C (en) Xinnaoshu dripping pill for invigorating qi and nourishing yin and its preparing method
CN1316959C (en) Acanthopanax bark-ginseng-Chinese angelica root-astragalus root dripping pill and its preparing method
CN1292741C (en) Ginseng and schisandra fruit dripping pill and its preparing method
CN1292736C (en) Dripping pill made from haw, chrysanthemum and Chinese wolfberry fruit and its preparing method
CN1301101C (en) Oral drip pill used for cough suppressing phlegm transforming and its preparation method
CN1317010C (en) Huoliguan dripping pill for tonifying heart and kidney and its preparing method
CN1682920A (en) Anshenning dripping pill for treating neurosism and its preparing method
CN1307983C (en) Mai-an dripping pill for treating hyperlipoproteinemia and its preparing method
CN1682806A (en) Ginseng and fleece-flower root dripping pill and its preparing method
CN1686384A (en) Guanxinning drip pill for treating heart disease and its preparation method
CN1686388A (en) Kangai drip pill for treating tumour, hepatitis B and its preparation method
CN1686477A (en) Lonicera flower mango drip pill and its preparation method
CN1686521A (en) Psoriasis drip pill and its preparation method
CN1292740C (en) Ginseng and Chinese angelica root dripping pill and its preparing method
CN1686518A (en) Ganoderma astragalus drip pill for treating heart spleen vacuity and its preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070103

Termination date: 20100218